[EN] COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES CUTANÉS
申请人:KAMARI PHARMA LTD
公开号:WO2021154966A1
公开(公告)日:2021-08-05
Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS
申请人:Kamari Pharma Ltd.
公开号:EP4096661A1
公开(公告)日:2022-12-07
Mild Fluorination of Chloropyridines with in Situ Generated Anhydrous Tetrabutylammonium Fluoride
作者:Laura J. Allen、Joseck M. Muhuhi、Douglas C. Bland、Rachel Merzel、Melanie S. Sanford
DOI:10.1021/jo5003054
日期:2014.6.20
This paper describes the fluorination of nitrogen heterocycles usinganhydrous NBu4F. Quinoline derivatives as well as a number of 3- and 5-substituted pyridines undergo high-yielding fluorination at room temperature using this reagent. These results with anhydrous NBu4F compare favorably to traditional halex fluorinationsusing alkali metal fluorides, which generally require temperatures of ≥100 °C